Добірка наукової літератури з теми "Antibiotic-associated diarrhoea"

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Antibiotic-associated diarrhoea".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Antibiotic-associated diarrhoea"

1

Overeem, Karlijn, Geertje van Soest, and Nettie Blankenstein. "Antibiotic-associated diarrhoea." British Journal of General Practice 58, no. 549 (April 1, 2008): 283.3–284. http://dx.doi.org/10.3399/bjgp08x279959.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Garg, Ritu, and Varsha Gupta. "Antibiotic associated diarrhoea." Journal of Gastrointestinal Infections 3, no. 1 (July 2012): 6–8. http://dx.doi.org/10.5005/jogi-3-1-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Riley, Thomas V. "Antibiotic-Associated Diarrhoea." PharmacoEconomics 10, no. 1 (July 1996): 1–3. http://dx.doi.org/10.2165/00019053-199610010-00001.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Hancock, Paul. "Antibiotic-associated diarrhoea." Reviews in Medical Microbiology 8 (1997): S69. http://dx.doi.org/10.1097/00013542-199712001-00038.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Coté, Gregory A., and Alan L. Buchman. "Antibiotic-associated diarrhoea." Expert Opinion on Drug Safety 5, no. 3 (April 13, 2006): 361–72. http://dx.doi.org/10.1517/14740338.5.3.361.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Martínez, Esteban, and Angeles Marcos. "Antibiotic-associated diarrhoea." Lancet 337, no. 8746 (April 1991): 911. http://dx.doi.org/10.1016/0140-6736(91)90238-k.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Beaugerie, Laurent, and Jean-Claude Petit. "Antibiotic-associated diarrhoea." Best Practice & Research Clinical Gastroenterology 18, no. 2 (April 2004): 337–52. http://dx.doi.org/10.1016/j.bpg.2003.10.002.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Barbut, F. "Managing antibiotic associated diarrhoea." BMJ 324, no. 7350 (June 8, 2002): 1345–46. http://dx.doi.org/10.1136/bmj.324.7350.1345.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Gustafsson, A. "Antibiotic-associated diarrhoea in horses." Equine Veterinary Education 14, no. 4 (January 5, 2010): 186. http://dx.doi.org/10.1111/j.2042-3292.2002.tb00168.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

McFarland, Lynne V. "Diarrhoea associated with antibiotic use." BMJ 335, no. 7610 (July 12, 2007): 54–55. http://dx.doi.org/10.1136/bmj.39255.829120.47.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Дисертації з теми "Antibiotic-associated diarrhoea"

1

Conway, Shaun. "Does eating live bio yogurt prevent antibiotic-associated diarrhoea?" Thesis, University of East Anglia, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.426778.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Gustafsson, Agneta. "Antibiotic associated diarrhea in horses : with special reference to Clostridium difficile /." Uppsala : Dept. of Large Animal Clinical Sciences, Swedish Univ. of Agricultural Sciences, 2004. http://epsilon.slu.se/v166.pdf.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Edwards-Marshall, Marva. "EFFECTIVENESS OF PROBIOTICS IN PREVENTING ANTIBIOTIC ASSOCIATED DIARRHEA AND CLOSTRIDIUM DIFFICILE IN LONG TERM CARE." Doctoral diss., University of Central Florida, 2010. http://digital.library.ucf.edu/cdm/ref/collection/ETD/id/2944.

Повний текст джерела
Анотація:
Purpose: Antibiotic associated diarrhea (AAD) and clostridium-difficile diarrhea (CDAD) are the most common forms of infectious diarrhea in long term care facilities. The purpose of this study is to determine the effectiveness of probiotics in preventing AAD and CDAD in the long term care geriatric population, and to identify interventions which can be used to improve clinical practice. Methods: This was a retrospective cohort study. The study population consisted of residents of a LTC facility who were sixty-five years of age and older who were administered antibiotic therapies with or without co-administration of probiotics. A data collection instrument which was created for this study was piloted prior to its use in the study. Chi-square test of independence and Cochran s Q were the proposed statistical analysis procedures used to determine relationships between variables. Results: Eighty-three residents received antibiotics. In the forty-four residents who were administered probiotic with antibiotic, five cases of diarrhea were reported. In the thirty-nine residents who received antibiotics without probiotics, two cases of diarrhea were reported. Analysis with chi-square test of independence comparing the relationship between antibiotic administration with and without probiotic and AAD prevention, was (X²(1) =1.041, p=0.308). No cases of CDAD were found in the group who received antibiotic (s) and a probiotic. One case of CDAD was found in the group which received no probiotic with the antibiotic. Analysis with chi-square test of independence comparing the relationship between antibiotic administration with or without probiotic and CDAD prevention was (X²(1) =1.142, p=0.285). Discussion/Implication: The results of this study showed no statistically significant evidence to support the effectiveness of probiotic use in the prevention of AAD or CDAD in this population. The incidence of AAD was higher in the group who received a probiotic at the time of antibiotic administration.
D.N.P.
School of Nursing
Health and Public Affairs
Nursing Practice DNP
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Thomas, Claudia. "The epidemiology and control of Clostridium difficile infection in a Western Australian hospital." University of Western Australia. School of Population Health, 2003. http://theses.library.uwa.edu.au/adt-WU2004.0011.

Повний текст джерела
Анотація:
[Truncated abstract] The prinicipal aim of this thesis was to explore the relationship between 3rd generation cephalosporin antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea (CDAD). This antibiotic class has been implicated in the aetiology of CDAD; therefore restriction of these antibiotics via antibiotic policies represents a potential strategy for prevention and control of CDAD. Successful control of CDAD in hospitals translates to improved quality of care for patients, and a reduction of pressure on hospital resources. Therefore, the objectives of this study were to determine whether 3rd generation cephalosporins were related to CDAD, to evaluate the effect of changes to antibiotic policy on the incidence of CDAD, and to determine the impact of CDAD on patient length of stay and hospital costs. The study was conducted in Sir Charles Gairdner Hospital (SCGH), a public teaching hospital located in Perth, the capital city of the state of Western Australia. Evidence for an association between 3rd generation cephalosporins and CDAD was obtained from studies of ecologic- and individual-level data. A time series analysis of the relationship between monthly consumption of 3rd generation cephalosporins and the incidence of CDAD in SCGH was undertaken covering the period 1994 to 2000. The results demonstrated a positive relationship between the use of 3rd generation cephalosporins and CDAD. A matched case-control study that involved 193 adult inpatients diagnosed with CDAD and 386 adult inpatients without CDAD, selected from the period 1996 to 2000, was conducted. Information was collected on exposure to 3rd generation cephalosporin antibiotics during hospitalisation, as well as exposure to other antibiotics and medications, procedures, and comorbidities. Results from conditional logistic regression analyses found CDAD cases were six times more likely to be exposed to 3rd generation cephalosporins during their admission, prior to the onset of diarrhoea, than controls (adjusted odds ratio [OR] = 6.17, 95% confidence interval [CI] = 1.56-24.37). Approximately one third of CDAD in the study population could be attributed to 3rd generation cephalosporins. CDAD cases were also four times more likely to have been exposed to either amoxicillin-clavulanate or ticarcillin-clavulanate (adjusted OR=4.23, 95% CI=1.81-9.93). In October 1998, an antibiotic policy was introduced at SCGH that restricted the use of ceftriaxone, the 3rd generation cephalosporin most commonly used by the hospital. During 1999 and 2000, the incidence of CDAD halved as ceftriaxone consumption fell in response to this policy. The effect of this policy was demonstrated in the time series model; during the post-policy period the relationship between ceftriaxone and CDAD that was evident prior to the policy was cancelled out. From the individual-level data, obtained from the case-control study, a reduction in the prevalence of exposure to 3rd generation cephalosporins from 11% to 1% accounted for a 30% reduction in the incidence of CDAD. Data from the case-control study was also used to analyse the independent contribution of CDAD to length of stay and admission costs using multiple linear regression
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Mosquito, Susan, Maria J. Pons, Maribel Riveros, Joaquim Ruiz, and Theresa J. Ochoa. "Diarrheagenic Escherichia coli Phylogroups Are Associated with Antibiotic Resistance and Duration of Diarrheal Episode." Hindawi Publishing Corporation, 2015. http://hdl.handle.net/10757/345715.

Повний текст джерела
Анотація:
Conventionally, in Escherichia coli, phylogenetic groups A and B1 are associated with commensal strains while B2 and D are associated with extraintestinal strains. The aim of this study was to evaluate diarrheagenic (DEC) and commensal E. coli phylogeny and its association with antibiotic resistance and clinical characteristics of the diarrheal episode. Phylogenetic groups and antibiotic resistance of 369 E. coli strains (commensal strains and DEC from children with or without diarrhea) isolated from Peruvian children <1 year of age were determined by a Clermont triplex PCR and Kirby-Bauer method, respectively. The distribution of the 369 E. coli strains among the 4 phylogenetic groups was A (40%), D (31%), B1 (21%), and B2 (8%). DEC-control strains were more associated with group A while DEC-diarrhea strains were more associated with group D (𝑃 < 0.05). There was a tendency (𝑃 = 0.06) for higher proportion of persistent diarrhea (≥14 days) among severe groups (B2 and D) in comparison with nonsevere groups (A and B1). Strains belonging to group D presented significantly higher percentages of multidrug resistance than the rest of the groups (𝑃 > 0.01). In summary, DEC-diarrhea strains were more associated with group D than strains from healthy controls.
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Маркевич, Віталій Едуардович, Виталий Эдуардович Маркевич, Vitalii Eduardovych Markevych, І. С. Бубнова та Є. Б. Небоян. "Використання препарату Біфіформ-Бебі в немовлят з антибіотик-асоційованою діареєю". Thesis, Видавництво СумДУ, 2012. http://essuir.sumdu.edu.ua/handle/123456789/27448.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Alhammad, Ali. "THE USE OF LACTOBACILLUS IN THE TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTION IN HOSPITALIZED ADULT PATIENTS." VCU Scholars Compass, 2009. http://hdl.handle.net/10156/2447.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Maia, Mariana de Sá Osório Dias. "Probiotics in the prevention of antibiotic-associated diarrhea in the pediatric population - A Systematic Review." Master's thesis, 2021. https://hdl.handle.net/10216/134456.

Повний текст джерела
Анотація:
Objetivos: A presente revisão sistemática visa avaliar a eficácia de probióticos na prevenção de diarreia associada aos antibióticos, na idade pediátrica. Métodos: Foi realizada uma revisão sistemática com análise qualitativa de ensaios clínicos randomizados. Os artigos foram pesquisados nas bases de dados PUBMED, Web of Science, CENTRAL, independentemente da linguagem, estado ou data da publicação. Estes foram sucessivamente selecionados de acordo com os critérios de elegibilidade definidos. Os critérios de Cochrane Risk of Bias foram aplicados para avaliar a qualidade dos estudos. Resultados: Foram incluídos cinco artigos, três destes sobre Lactobacillus rhamnosus GG e dois com foco em Lactobacillus reuteri DSM 17938. Os resultados obtidos sugeriram que um uso concomitante de antibióticos e Lactobacillus GG foi consistentemente eficaz na prevenção da diarreia associada aos antibióticos, sendo este dado estatisticamente significativo. Os ensaios clínicos que estudaram Lactobacillus reuteri DSM 17938 não encontraram evidência da sua eficácia. Contudo, os autores consideram o tempo de follow-up foi um fator limitante das suas conclusões. Conclusões: Esta revisão sistemática encontrou evidência da eficácia de Lactobacillus GG como medida preventiva da diarreia associada aos antibióticos, na idade pediátrica, mas não relativamente a Lactobacillus reuteri DSM 17938. Assim, recomendamos que os dois probióticos continuem a ser estudados, nomeadamente com recurso a ensaios clínicos randomizados.
Objectives: The aim of this systematic review is to assess the effectiveness of probiotics in the prevention of AAD in the pediatric population. Methods: A systematic review of randomized controlled trials (RCTs) was conducted for greater level of evidence. Articles were electronically searched in PUBMED, Web of Science, CENTRAL, irrespective of language, publication status, or date of publication. Records were successively selected according to the criteria for eligibility. The quality of each trial was assessed using the Cochrane Risk of Bias Criteria. Results: Five papers were included, between these, three on Lactobacillus rhamnosus GG and two on Lactobacillus reuteri DSM 17938. Results suggest that the concomitant use of Lactobacillus GG was consistently effective in the prevention of AAD, this being statistically significant. Lactobacillus GG reduced the incidence of AAD to one third. RCTs on Lactobacillus reuteri DSM 17938 found no evidence of its prophylactic use for pediatric AAD. However, the authors believe that an extended follow-up would lead to greater conclusions. Conclusions: This systematic review provides evidence to recommend Lactobacillus GG as a preventive measure of AAD in children but Lactobacillus reuteri DSM 17938 was not found to be effective. We encourage further investigation on both probiotics, mainly via randomized controlled trials.
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Maia, Mariana de Sá Osório Dias. "Probiotics in the prevention of antibiotic-associated diarrhea in the pediatric population - A Systematic Review." Dissertação, 2021. https://hdl.handle.net/10216/134456.

Повний текст джерела
Анотація:
Objetivos: A presente revisão sistemática visa avaliar a eficácia de probióticos na prevenção de diarreia associada aos antibióticos, na idade pediátrica. Métodos: Foi realizada uma revisão sistemática com análise qualitativa de ensaios clínicos randomizados. Os artigos foram pesquisados nas bases de dados PUBMED, Web of Science, CENTRAL, independentemente da linguagem, estado ou data da publicação. Estes foram sucessivamente selecionados de acordo com os critérios de elegibilidade definidos. Os critérios de Cochrane Risk of Bias foram aplicados para avaliar a qualidade dos estudos. Resultados: Foram incluídos cinco artigos, três destes sobre Lactobacillus rhamnosus GG e dois com foco em Lactobacillus reuteri DSM 17938. Os resultados obtidos sugeriram que um uso concomitante de antibióticos e Lactobacillus GG foi consistentemente eficaz na prevenção da diarreia associada aos antibióticos, sendo este dado estatisticamente significativo. Os ensaios clínicos que estudaram Lactobacillus reuteri DSM 17938 não encontraram evidência da sua eficácia. Contudo, os autores consideram o tempo de follow-up foi um fator limitante das suas conclusões. Conclusões: Esta revisão sistemática encontrou evidência da eficácia de Lactobacillus GG como medida preventiva da diarreia associada aos antibióticos, na idade pediátrica, mas não relativamente a Lactobacillus reuteri DSM 17938. Assim, recomendamos que os dois probióticos continuem a ser estudados, nomeadamente com recurso a ensaios clínicos randomizados.
Objectives: The aim of this systematic review is to assess the effectiveness of probiotics in the prevention of AAD in the pediatric population. Methods: A systematic review of randomized controlled trials (RCTs) was conducted for greater level of evidence. Articles were electronically searched in PUBMED, Web of Science, CENTRAL, irrespective of language, publication status, or date of publication. Records were successively selected according to the criteria for eligibility. The quality of each trial was assessed using the Cochrane Risk of Bias Criteria. Results: Five papers were included, between these, three on Lactobacillus rhamnosus GG and two on Lactobacillus reuteri DSM 17938. Results suggest that the concomitant use of Lactobacillus GG was consistently effective in the prevention of AAD, this being statistically significant. Lactobacillus GG reduced the incidence of AAD to one third. RCTs on Lactobacillus reuteri DSM 17938 found no evidence of its prophylactic use for pediatric AAD. However, the authors believe that an extended follow-up would lead to greater conclusions. Conclusions: This systematic review provides evidence to recommend Lactobacillus GG as a preventive measure of AAD in children but Lactobacillus reuteri DSM 17938 was not found to be effective. We encourage further investigation on both probiotics, mainly via randomized controlled trials.
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Chia, Ju Hsin, and 賈儒馨. "Molecular epidemiology, drug resistance, and pathogenesis of antibiotic-associated diarrhea-related Clostridium difficile and Clostridium innocuum." Thesis, 2015. http://ndltd.ncl.edu.tw/handle/r65rw6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Книги з теми "Antibiotic-associated diarrhoea"

1

Borriello, S. P. Antibiotic Associated Diarrhoea and Colitis: The Role of Clostridium Difficile in Gastrointestinal Disorders. Springer, 2012.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Antibiotic Associated Diarrhoea and Colitis: The role of Clostridium difficile in gastrointestinal disorders. Springer, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Borriello, S. P. Antibiotic Associated Diarrhoea and Colitis: The Role of Clostridium Difficile in Gastrointestinal Disorders. Springer, 2011.

Знайти повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Bowker, Lesley K., James D. Price, Ku Shah, and Sarah C. Smith. Infection and immunity. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780198738381.003.0024.

Повний текст джерела
Анотація:
This chapter provides information on the ageing immune system, an overview of infection in older people, antibiotic use in older patients, meticillin-resistant Staphylococcus aureus (MRSA), disease caused by MRSA, Clostridium difficile-associated diarrhoea, near-patient urine tests, asymptomatic bacteriuria, urinary tract infection, treatment of urinary tract infection, recurrent urinary tract infection, and varicella-zoster infection.
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Lenoir-Wijnkoop, Irene, Mark J. C. Nuijten, Joyce Craig, Christopher C. Butler, and Eric Claassen. Probiotics and Cost-Benefits in the Prevention of Antibiotic-Associated Diarrhea: A New Dimension to Consider. Frontiers Media SA, 2014. http://dx.doi.org/10.3389/978-2-88919-233-5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Частини книг з теми "Antibiotic-associated diarrhoea"

1

Borriello, S. P., and C. Roffe. "The normal microflora and antibiotic-associated diarrhoea and colitis." In Medical Importance of the Normal Microflora, 371–87. Boston, MA: Springer US, 1999. http://dx.doi.org/10.1007/978-1-4757-3021-0_14.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Corthier, G. "Antibiotic-Associated Diarrhoea: Treatments by Living Organisms given by the Oral Route (Probiotics)." In Probiotics 2, 40–64. Dordrecht: Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-011-5860-2_3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Theriot, Casey, and Vincent B. Young. "Antibiotic-Associated Diarrhea." In Encyclopedia of Metagenomics, 31–36. Boston, MA: Springer US, 2015. http://dx.doi.org/10.1007/978-1-4899-7475-4_64.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
4

Champion, Howard R., Nova L. Panebianco, Jan J. De Waele, Lewis J. Kaplan, Manu L. N. G. Malbrain, Annie L. Slaughter, Walter L. Biffl, et al. "Antibiotic-Associated Diarrhea." In Encyclopedia of Intensive Care Medicine, 201. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_1129.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Theriot, Casey, and Vincent B. Young. "Antibiotic-Associated Diarrhea." In Encyclopedia of Metagenomics, 1–7. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-6418-1_64-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Finberg, Robert W., and Roy Guharoy. "Antibiotic-Associated Diarrhea." In Clinical Use of Anti-infective Agents, 127–29. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-67459-5_19.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Henry, David Elisha, and V. Venkateswara Rao. "Antibiotic-Associated Diarrhea and Update on Probiotics Recommendations." In Probiotic Research in Therapeutics, 141–66. Singapore: Springer Singapore, 2021. http://dx.doi.org/10.1007/978-981-33-6236-9_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Szajewska, Hania. "Probiotics in Antibiotic-Associated Diarrhea and Clostridium difficile Infection." In Probiotics in Pediatric Medicine, 207–18. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60327-289-6_15.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Surawicz, Christina M. "Biotherapeutic Agents in the Prevention of Antibiotic-Associated Diarrhea." In Biotherapeutic Agents and Infectious Diseases, 145–58. Totowa, NJ: Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-711-6_6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Surawicz, Christina M. "Probiotics and Antibiotic-Associated Diarrhea and Clostridium difficile Infection." In Prebiotics and Probiotics Science and Technology, 825–43. New York, NY: Springer New York, 2009. http://dx.doi.org/10.1007/978-0-387-79058-9_21.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Antibiotic-associated diarrhoea"

1

Milenković, B., I. Andrijevic, S. Dimic Janjic, S. Milutinov Ilic, I. Kopitovic, M. Stjepanovic, A. Andrijevic, J. Jankovic, and S. Mitrovic. "Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea in hospitalized adult patients with lower respiratory tract infections." In ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.2604.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Nagao, T., Y. Hanawa, K. Sawada, I. Tsukimoto, I. Ikeda, M. Komazawa, K. Shiraki, et al. "THE VITAMIN K DEFICIENCY IN INFANCY IN JAPAN -- THE SECOND NATIONWIDE SURVEY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644263.

Повний текст джерела
Анотація:
Questionnaires were sent to 1,218 hospitals with more than 200 beds, in order to know the incidence of hemorrhagic disease due to vitamin K deficiency in infancy beyond 2 weeks after birth, during 4 and a half years, i.e. from January 1981 to June 1985. Out of the 534 cases reported, 407 had no obvious reasons for vitamin K deficiency: "idiopathic vitamin K deficiency in infancy". Other 68 cases had bleedingepisodes due to vitamin K deficiency associated with hepatobiliary lesions (e.g.congenital bile duct atresia), chronic diarrhea, long term antibiotic therapy and so on: "secondary vitamin K deficiencyin infancy". The third group consisting of 59 cases was so called "near miss" type, in which hemorrhagic tendency was discovered at the time of mass screening tests for vitamin K deficiency or by chance withoutany clinical hemorrhage. In the idiopatic group, 345 cases (84.8%) developed their bleeding episodes between 21 and 59 days of age, and 368 cases (90.4%) were wholly breast-fed. Intracranial hemorrhage was seen in 338 cases (83.0%) of this group. In most cases of this series (97.3%),no vitamin K was supplemented after birth. Administration of vitamin K is an urgent routine procedure during the first one or two months of life for all newbornbabies, although the incidence of the idiopathic vitamin K deficiency in infancyhas not decreased significantly comparedto the results of the first nation-wide survey (Jan. 1978 - Dec. 1980). This study was sponsored by the Ministry of Health and Welfare of Japan.
Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Antibiotic-associated diarrhoea"

1

Zhou, Xin, Xiaobo Zhang, Rui Gao, Min Xiong, and Tao Shen. Efficacy of Xianglian pill for antibiotic-associated diarrhea: a protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, October 2020. http://dx.doi.org/10.37766/inplasy2020.10.0112.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії